Skip to content
10-Q

Quarterly Report

Renalytix plc RENXF RNLXY

0000950170-24-060033

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · May 14, 2024 154.37M sh
Shares Diluted Q3 2024 · Mar 31, 2024 97.65M sh
Shares Diluted Q3 2024 · Mar 31, 2024 98.18M sh
Shares Diluted Q3 2024 · Mar 31, 2023 85.56M sh
Shares Diluted Q3 2024 · Mar 31, 2023 78.37M sh
Operating Cash Flow Q3 2024 · Mar 31, 2024 −$22.29M
Operating Cash Flow Q3 2024 · Mar 31, 2023 −$25.45M
Cash And Equivalents Q3 2024 · Mar 31, 2024 $4.7M
Cash And Equivalents Q3 2024 · Jun 30, 2023 $24.68M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$11.11M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$7.96M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.49M
Stockholders Equity Q3 2024 · Jun 30, 2023 $6.97M
Stockholders Equity Q3 2024 · Mar 31, 2023 $18.1M
Stockholders Equity Q3 2024 · Dec 31, 2022 $8.89M
Stockholders Equity Q3 2024 · Sep 30, 2022 $18.84M
Stockholders Equity Q3 2024 · Jun 30, 2022 $30.61M
Current Liabilities Q3 2024 · Mar 31, 2024 $14.99M
Current Liabilities Q3 2024 · Jun 30, 2023 $16.14M
Total Liabilities Q3 2024 · Mar 31, 2024 $19.88M
Total Liabilities Q3 2024 · Jun 30, 2023 $23.66M
Current Assets Q3 2024 · Mar 31, 2024 $6.34M
Current Assets Q3 2024 · Jun 30, 2023 $26.88M
Total Assets Q3 2024 · Mar 31, 2024 $8.77M
Total Assets Q3 2024 · Jun 30, 2023 $30.63M
Eps Diluted Q3 2024 · Mar 31, 2024 −$0.08
Eps Diluted Q3 2024 · Mar 31, 2024 −$0.27
Eps Diluted Q3 2024 · Mar 31, 2023 −$0.14
Eps Diluted Q3 2024 · Mar 31, 2023 −$0.44
Eps Basic Q3 2024 · Mar 31, 2024 −$0.08
Eps Basic Q3 2024 · Mar 31, 2024 −$0.27
Eps Basic Q3 2024 · Mar 31, 2023 −$0.14
Eps Basic Q3 2024 · Mar 31, 2023 −$0.44
Sga Expense Q3 2024 · Mar 31, 2024 $3.85M
Sga Expense Q3 2024 · Mar 31, 2024 $15.25M
Sga Expense Q3 2024 · Mar 31, 2023 $7.1M
Sga Expense Q3 2024 · Mar 31, 2023 $22.16M
Net Income Q3 2024 · Mar 31, 2024 −$7.74M
Net Income Q3 2024 · Mar 31, 2024 −$26.38M
Net Income Q3 2024 · Dec 31, 2023 −$8.49M
Net Income Q3 2024 · Sep 30, 2023 −$10.15M
Net Income Q3 2024 · Mar 31, 2023 −$12.11M
Net Income Q3 2024 · Mar 31, 2023 −$34.5M
Net Income Q3 2024 · Dec 31, 2022 −$10.44M
Net Income Q3 2024 · Sep 30, 2022 −$11.95M
Operating Income Q3 2024 · Mar 31, 2024 −$6.55M
Operating Income Q3 2024 · Mar 31, 2024 −$24.08M
Operating Income Q3 2024 · Mar 31, 2023 −$10.92M
Operating Income Q3 2024 · Mar 31, 2023 −$32.29M
Gross Profit Q3 2024 · Mar 31, 2024 −$66K
Gross Profit Q3 2024 · Mar 31, 2024 $120K
Gross Profit Q3 2024 · Mar 31, 2023 $121K
Gross Profit Q3 2024 · Mar 31, 2023 $875K
Cost Of Revenue Q3 2024 · Mar 31, 2024 $601K
Cost Of Revenue Q3 2024 · Mar 31, 2024 $1.58M
Cost Of Revenue Q3 2024 · Mar 31, 2023 $603K
Cost Of Revenue Q3 2024 · Mar 31, 2023 $2.01M